[Clinical evaluation of bestatin (NK-421) supplementing radiotherapy in the treatment of lung cancer].
D000230:Adenocarcinoma / Q000532:radiotherapy / Q000628:therapy; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage
D000903:Antibiotics, Antineoplastic; D007930:Leucine; C012211:ubenimex